NCT03540875

Brief Summary

This study compares automated administration of propofol and remifentanil versus manual administration during general anesthesia for a surgery. The closed-loop coadministration of propofol and remifentanil is guided by qCon and qNox indexes from the Conox monitor.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2018

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 30, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

July 2, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2019

Completed
Last Updated

November 5, 2021

Status Verified

October 1, 2021

Enrollment Period

8 months

First QC Date

May 6, 2018

Last Update Submit

October 28, 2021

Conditions

Keywords

Anesthesia, generalTotal intravenous anesthesiaClosed loop anesthesiaConoxEEG monitoringqConqNox

Outcome Measures

Primary Outcomes (1)

  • Adequate sedation

    Percentage of time with qCon index within the 40-60 range as recommended by the manufacturer of Conox monitor. Data from the Conox monitor (signal quality index, qCon index, qNox index, Suppression ratio) are recorded every second.

    Start of general anesthesia maintenance, i.e. qCon below 60 for 30 consecutive seconds for the first time, until the end of propofol et remifentanil infusion

Secondary Outcomes (9)

  • Adequate analgesia

    Start of general anesthesia maintenance, i.e. qNox below 60 for 30 consecutive seconds for the first time, until the end of propofol et remifentanil infusion

  • Occurrence of Burst Suppression Ratio (bsr)

    Intraoperative period

  • Dose of hypnotic drug

    Intraoperative period

  • Dose of analgesic drug

    Intraoperative period

  • Medical interventions on the dosage of drugs

    Intraoperative period

  • +4 more secondary outcomes

Study Arms (2)

Full automation group

EXPERIMENTAL

Full automation control of propofol and remifentanil

Device: Closed loop anesthesiaDrug: PropofolDrug: Remifentanil

Control group

OTHER

Manual control of of propofol and remifentanil using TCI system

Drug: PropofolDrug: Remifentanil

Interventions

Propofol and Remifentanil are administered automatically using a closed-loop system. The goal of this study is to compare manual titration versus automated titration of propofol and remifentanil in adult patients undergoing surgery guided by the electro-cortical activity. The aim in both group is to maintain the qCon in the range 40-60 during induction and maintenance of general anesthesia using the propofol in TCI mode. But also the qNox in the range 40-60 using remifentanil. The controller is based on a Proportional-Integral-derivative algorithm which steers a target to the pumps during induction and maintenance of general anesthesia.

Full automation group

The dosage is modified automatically by the device or according to the new medical prescription.

Control groupFull automation group

The dosage is modified automatically by the device or according to the new medical prescription.

Control groupFull automation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled surgery for at least one hour
  • Consent for participation
  • Affiliation to the social security system

You may not qualify if:

  • Pregnant or breastfeeding women
  • Patients for which Conox monitor should not be used
  • Allergies to propofol or remifentanil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Service d'Anesthésie Réanimation Chirurgicale, CHU Besançon

Besançon, Bourgogne-Franche-Comté, 25030, France

Location

Service d'Anesthésie du Centre Clinical

Soyaux, Poitou-Charentes, 16800, France

Location

Service d'Anesthésie, Hôpital Foch

Suresnes, Île-de-France Region, 92151, France

Location

Related Publications (2)

  • Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.

  • Jensen EW, Valencia JF, Lopez A, Anglada T, Agusti M, Ramos Y, Serra R, Jospin M, Pineda P, Gambus P. Monitoring hypnotic effect and nociception with two EEG-derived indices, qCON and qNOX, during general anaesthesia. Acta Anaesthesiol Scand. 2014 Sep;58(8):933-41. doi: 10.1111/aas.12359. Epub 2014 Jul 4.

MeSH Terms

Interventions

PropofolRemifentanil

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Marc Fischler, MD

    Hôpital Foch

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2018

First Posted

May 30, 2018

Study Start

July 2, 2018

Primary Completion

February 18, 2019

Study Completion

February 18, 2019

Last Updated

November 5, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations